Replimune: Perhaps The FDA Shakeup Will Get A Mulligan For RP1
Source: SeekingAlpha
2026-05-13 13:00:49 ET
Topline Summary And Update
Read the full article on Seeking Alpha
For further details see:
Replimune: Perhaps The FDA Shakeup Will Get A Mulligan For RP1
Replimune Group Inc.
NASDAQ: REPL
REPL Trading
-2.99% G/L:
$5.035 Last:
1,693,266 Volume:
$5.06 Open:
REPL Latest News
REPL Stock Data
$646,543,607
51,607,887
0.33%
61
N/A
Biotechnology & Life Sciences
Healthcare
US
Woburn
